# Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

> **NCT01244789** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Danish Gynecological Cancer Group** · enrollment: 244 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** carboplatin and paclitaxel
- **OTHER:** observation

## Key facts

- **NCT ID:** NCT01244789
- **Lead sponsor:** Danish Gynecological Cancer Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-12
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- European Organisation for Research and Treatment of Cancer - EORTC
- Arbeitsgemeinschaft Gynaekologische Onkologie Austria
- North Eastern German Society of Gynaecological Oncology
- Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- Belgian Gynaecological Oncology Group
- Mario Negri Gynecologic Oncology group (MaNGO)
- Israeli Society of Gynecologic Oncology
- Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO)
- Central and Eastern European Oncology Group

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244789, "Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01244789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*